GIXERTIV Trademark

Trademark Overview


On Tuesday, October 5, 2021, a trademark application was filed for GIXERTIV with the United States Patent and Trademark Office. The USPTO has given the GIXERTIV trademark a serial number of 97060317. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 14, 2024. This trademark is owned by Pfizer Inc.. The GIXERTIV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
gixertiv

General Information


Serial Number97060317
Word MarkGIXERTIV
Filing DateTuesday, October 5, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, October 8, 2021NEW APPLICATION ENTERED
Friday, October 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 14, 2022ASSIGNED TO EXAMINER
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 31, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 31, 2023SOU EXTENSION 1 FILED
Tuesday, January 31, 2023SOU EXTENSION 1 GRANTED
Thursday, February 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 26, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 28, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 28, 2023SOU EXTENSION 2 FILED
Friday, July 28, 2023SOU EXTENSION 2 GRANTED
Tuesday, August 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 26, 2024SOU EXTENSION 3 FILED
Friday, January 26, 2024SOU EXTENSION 3 GRANTED
Monday, October 14, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, October 14, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, January 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED